Pharmabiz35m
Qiagen introduces novel tools for customizing digital PCR assays and NGS panels for microbial analysis
Venlo, the Netherlands Saturday, November 30, 2024, 10:00 Hrs [IST] ...
Pharmabiz1h
Boehringer Ingelheim introduces Eurican L4 vaccine to protect dogs against leptospirosis
Boehringer Ingelheim introduces Eurican L4 vaccine to protect dogs against leptospirosis: Ingelheim, Germany Saturday, ...
Pharmabiz2h
Indian healthcare industry sees fusion of AI & wearable technology to reduce emergency medical interventions
Indian healthcare industry sees fusion of AI & wearable technology to reduce emergency medical interventions: Nandita Vijayasimha, Bengaluru Saturday, November 30, 2024, 08:00 Hrs ...
Pharmabiz2h
India takes centre-stage in clinical trials for HIV/AIDS drug
India takes centre-stage in clinical trials for HIV/AIDS drug: Nandita Vijayasimha, Bengaluru Saturday, November 30, 2024, 08:00 Hrs [IST] India has taken centre-stage in clinical ...
Pharmabiz2h
DGTR reviews PUC/PCN methodology for acrylonitrile butadiene rubber investigation
DGTR reviews PUC/PCN methodology for acrylonitrile butadiene rubber investigation: Shardul Nautiyal, Mumbai Saturday, November 30, 2024, 08:00 Hrs [IST] In order to define the sco ...
Pharmabiz2h
Miror expands women’s health support across India in partnership with NHM: Expert
Miror expands women’s health support across India in partnership with NHM: Expert: Shardul Nautiyal, Mumbai Saturday, November 30, 2024, 08:00 Hrs [IST] To redefine women's heal ...
Pharmabiz2h
Imports of surgicals grew 11.5 per cent in H1 FY25
Imports of surgicals to the country have reported growth of 11.5 per cent in the first half of the current fiscal year as against the same period of previous fiscal year, and 12.3 per cent growth for ...
Pharmabiz21h
UK MHRA approves new diagnostic agent, flortaucipir for adult patients showing signs of cognitive impairment for Alzheimer’s disease
UK MHRA approves new diagnostic agent, flortaucipir for adult patients showing signs of cognitive impairment for Alzheimer’s disease: United Kingdom Friday, November 29, 2024, 1 ...
Pharmabiz18h
BioArctic’s partner Eisai launches Leqembi in South Korea to treat MCI due to AD or mild AD dementia
BioArctic’s partner Eisai launches Leqembi in South Korea to treat MCI due to AD or mild AD dementia: Stockholm, Sweden Friday, November 29, 2024, 16:00 Hrs [IST] BioArctic ABs ...
Pharmabiz19h
Innovent announces first-time inclusion of Sintbilo and new indication for olverembatinib in China’s National Reimbursement Drug List
Innovent announces first-time inclusion of Sintbilo and new indication for olverembatinib in China’s National Reimbursement Drug List: San Francisco, US Friday, November 29, 202 ...
Pharmabiz21h
CDSCO declares 60 drug samples tested in October as NSQ, three as spurious
CDSCO declares 60 drug samples tested in October as NSQ, three as spurious: Our Bureau, New Delhi Friday, November 29, 2024, 13:30 Hrs [IST] The Central Drugs Standard Control Org ...
Pharmabiz20h
CureSMA Foundation of India lauds government and judiciary for historic Rs. 900+ crore allocation to rare disease treatment
CureSMA Foundation of India lauds government and judiciary for historic Rs. 900+ crore allocation to rare disease treatment: Our Bureau, Mumbai Friday, November 29, 2024, 14:30 Hr ...